Murray D. Bailey
35Patents
15h-index
49Co-inventors
77Inventor score
Filing activity: Dec 17, 1996 → Apr 3, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6323180A | Hepatitis C inhibitor tri-peptides | Chemistry; Metallurgy | 134 | Expired |
| US6534523B1 | Hepatitis C inhibitor tri-peptides | Chemistry; Metallurgy | 118 | Expired |
| US6420380B2 | Hepatitis C inhibitor tri-peptides | Chemistry; Metallurgy | 111 | Expired |
| US6410531B1 | Hepatitis C inhibitor tri-peptides | Chemistry; Metallurgy | 110 | Expired |
| US6767991B1 | Hepatitis C inhibitor peptides | Chemistry; Metallurgy | 69 | Expired |
| US6268207A | Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester | Chemistry; Metallurgy | 66 | Expired |
| US7091184B2 | Hepatitis C inhibitor tri-peptides | Human Necessities | 52 | Expired |
| US6329417A | Hepatitis C inhibitor tri-pepitides | Chemistry; Metallurgy | 51 | Expired |
| US6329379A | Hepatitis C inhibitor tri-peptides | Chemistry; Metallurgy | 49 | Expired |
| US6143715A | Hepatitis C inhibitor peptide analogues | Chemistry; Metallurgy | 43 | Expired |
| US6908901B2 | Hepatitis C inhibitor peptide analogs | Emerging Cross-Sectional Technologies | 41 | Expired |
| US7504378B2 | Macrocyclic peptides active against the hepatitis C virus | Human Necessities | 34 | Active |
| USRE40525E1 | Hepatitis C inhibitor tri-peptides | General | 28 | Expired |
| US7585845B2 | Hepatitis C inhibitor compounds | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7939667B2 | Hepatitis C inhibitor compounds | Emerging Cross-Sectional Technologies | 16 | Active |
| US8067438B2 | Hepatitis C inhibitor compounds | Emerging Cross-Sectional Technologies | 13 | Active |
| US7642235B2 | Macrocyclic peptides active against the hepatitis C virus | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7511157B2 | Hepatitis C inhibitor dipeptide analogs | Human Necessities | 11 | Expired |
| US6291640A | Peptidomimetic inhibitors of the human cytomegalovirus protease | Human Necessities | 4 | Expired |
| US7705146B2 | Hepatitis C inhibitor peptide analogs | Chemistry; Metallurgy | 4 | Active |
| US8338441B2 | Inhibitors of human immunodeficiency virus replication | Chemistry; Metallurgy | 3 | Active |
| US8377960B2 | Inhibitors of human immunodeficiency virus replication | Chemistry; Metallurgy | 3 | Active |
| US8841331B2 | Inhibitors of human immunodeficiency virus replication | Chemistry; Metallurgy | 2 | Active |
| US9249158B2 | Cytomegalovirus inhibitor compounds | Chemistry; Metallurgy | 2 | Active |
| US8461180B2 | Inhibitors of human immunodeficiency virus replication | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.